Impact of Inhaled PT003 on Complexity and Variability of Tidal Breathing and Oscillatory Mechanics in Stable COPD Patient
Stopped Following Brexit and the unavailability of the experimental drug (PT003) in France, the study was terminated prematurely.
Conditions
Interventions
- DRUG: Formoterol-glycopyrronium co suspension (PT003)
Sponsor
University Hospital, Lille
Collaborators